DK1886694T3 - Peroral lægemiddelform med dienogest og ethinylestradiol til kontraception - Google Patents

Peroral lægemiddelform med dienogest og ethinylestradiol til kontraception

Info

Publication number
DK1886694T3
DK1886694T3 DK06016694T DK06016694T DK1886694T3 DK 1886694 T3 DK1886694 T3 DK 1886694T3 DK 06016694 T DK06016694 T DK 06016694T DK 06016694 T DK06016694 T DK 06016694T DK 1886694 T3 DK1886694 T3 DK 1886694T3
Authority
DK
Denmark
Prior art keywords
dienogest
ethinylestradiol
contraception
oral drug
drug form
Prior art date
Application number
DK06016694T
Other languages
Danish (da)
English (en)
Inventor
Ralf Ladwig
Herbert Wiesinger
Sabine Fricke
Alexander Buske
Hagen Gerecke
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1886694T3 publication Critical patent/DK1886694T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK06016694T 2006-08-10 2006-08-10 Peroral lægemiddelform med dienogest og ethinylestradiol til kontraception DK1886694T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06016694A EP1886694B1 (de) 2006-08-10 2006-08-10 Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption

Publications (1)

Publication Number Publication Date
DK1886694T3 true DK1886694T3 (da) 2009-09-28

Family

ID=37561777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06016694T DK1886694T3 (da) 2006-08-10 2006-08-10 Peroral lægemiddelform med dienogest og ethinylestradiol til kontraception

Country Status (18)

Country Link
EP (1) EP1886694B1 (el)
AR (1) AR062323A1 (el)
AT (1) ATE432714T1 (el)
CL (1) CL2007002323A1 (el)
CY (1) CY1110348T1 (el)
DE (1) DE502006003892D1 (el)
DK (1) DK1886694T3 (el)
DO (1) DOP2007000122A (el)
ES (1) ES2327665T3 (el)
HR (1) HRP20090438T1 (el)
NO (1) NO20091057L (el)
PE (1) PE20080541A1 (el)
PL (1) PL1886694T3 (el)
PT (1) PT1886694E (el)
SI (1) SI1886694T1 (el)
TW (1) TW200817012A (el)
UY (1) UY30530A1 (el)
WO (1) WO2008017331A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010003711B4 (de) 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
CN115487198B (zh) * 2022-09-20 2024-01-02 华中药业股份有限公司 一种快溶出度的左炔诺孕酮制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
DE10218107A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen

Also Published As

Publication number Publication date
TW200817012A (en) 2008-04-16
WO2008017331A2 (de) 2008-02-14
EP1886694A1 (de) 2008-02-13
DE502006003892D1 (de) 2009-07-16
CY1110348T1 (el) 2015-04-29
DOP2007000122A (es) 2008-02-15
UY30530A1 (es) 2008-03-31
EP1886694B1 (de) 2009-06-03
PE20080541A1 (es) 2008-07-10
SI1886694T1 (sl) 2009-10-31
NO20091057L (no) 2009-03-09
AR062323A1 (es) 2008-10-29
HRP20090438T1 (en) 2009-09-30
PT1886694E (pt) 2009-08-17
CL2007002323A1 (es) 2008-02-15
ATE432714T1 (de) 2009-06-15
WO2008017331A3 (de) 2009-01-08
ES2327665T3 (es) 2009-11-02
PL1886694T3 (pl) 2009-11-30

Similar Documents

Publication Publication Date Title
DK2444806T3 (da) Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til deres fremstilling og anvendelse
IL188751A0 (en) Oral contraception with trimegestone
IL204536A (en) 6il anti-receptor antibodies and medical preparations containing them
DK3207941T6 (da) Fremgangsmåder og sammensætninger baseret på diphtheritoksin-interleukin-3-konjugater
EP1991171A4 (en) STRUCTURE FOR REUNNING AND RETAINING ORTHOPEDIC IMPLANTS IN SEVERAL PARTS
ZA200810116B (en) Pharmaceutical composition comprising amlodipine and losartan
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
HK1126380A1 (en) Dentition correcting device
IL196571A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
IL196113A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
NO20071297L (no) Farmasøytisk sammenseting omfattende drospirenon og etynylestradiol
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
DK3181691T3 (da) Anti-fgf23-antistof og en farmaceutisk sammensætning omfattende samme
EP1996209A4 (en) CONTRACEPTIVE COMPOSITION
EP2138473A4 (en) PIEZOELECTRIC CERAMIC COMPOSITION AND PIEZOELECTRIC DEVICE
GB0614365D0 (en) Pharmaceutical compositions and their use
EP1871269A4 (en) PASSAGE ENLARGING DEVICE FOR PATIENTS
DK1886694T3 (da) Peroral lægemiddelform med dienogest og ethinylestradiol til kontraception
ZA200707912B (en) Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol
EP2067480A4 (en) MUSCLIN RECEPTOR AND USE THEREOF
DK1787649T3 (da) Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception
DK2231603T3 (da) Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
TWM300368U (en) Mask supporter for leading and position
ITMI20061957A1 (it) Controled release macrolide pharmaceutical formulations